Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 70-76, Vol. 66, No. 1
Departments of Medical
Microbiology1 and
Medical
Chemistry,2 Vrije Universiteit, Medical
School, 1081 BT Amsterdam, The Netherlands, and
Regional
Blood Transfusion Center, Nantes, France3
Received 3 July 1997/Returned for modification 5 September
1997/Accepted 10 October 1997
Helicobacter pylori NCTC 11637 lipopolysaccharide (LPS)
expresses the human blood group antigen Lewis x (Lex) in a
polymeric form. Lex is
Helicobacter pylori is
involved in the pathogenesis of gastritis, gastric glandular atrophy,
duodenal and gastric ulcer, gastric adenocarcinoma, and
mucosa-associated lymphoid tissue lymphoma (12). How
bacteria belonging to a single species can give rise to such a
diversity of disease entities is currently under investigation. H. pylori is genetically very diverse (9):
strains from different sources all are different from each other at the
DNA level (15). This genetic heterogeneity is in part due to
the natural competence of H. pylori that renders this
bacterium naturally transformable (24). In addition, it has
been reported that recombinational events involving insertion elements
occur (7). A mechanism used by other mucosal pathogens like
Haemophilus influenzae (19) and
Neisseria spp. (30) to increase diversity is
phase variation. Phase variation (also called antigenic variation) is
the reversible on-and-off switching of surface epitopes, e.g., those
present on adhesins or lipopolysaccharide (LPS). Switch frequencies of 0.1% in these species are common. Genetically, this is paralleled by
on-and-off switching of specific genes coding for surface structures, such as the glycosyltransferase genes involved in LPS biosynthesis. Often, those glycosyltransferase genes contained oligonucleotide repeats in the 5' end, and one mechanism for phase variation involved replication errors due to slipped-strand base pairing in the repeat region. Recently, oligonucleotide repeats have been identified in the
fucosyltransferase (FucT) genes of H. pylori (8, 16, 23). The result of phase variation is a more versatile, more heterogeneous microorganism that can cope better with a variety of
different environments: with one set of genes switched on, the
microorganism may be able to adhere to mucosal cells of the nasopharynx
but not to survive complement attack in serum; with that particular set
switched off, the reverse may apply.
H. pylori LPS O antigen expresses Lewis x and/or y (Fig.
1), and only 15% of the strains tested
lacked these blood group antigens (22). The surface
localization of the bacterial Lewis antigens was demonstrated by
immunoelectron microscopy (6, 21). The enzymatic activity of
two enzymes involved in LPS O-antigen biosynthesis (
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phase Variation in Helicobacter
pylori Lipopolysaccharide
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-D-galactose-(1-4)-[
-L-fucose-(1-3)]-
-D-acetylglucosamine. Schematically the LPS structure is
(Lex)n-core-lipid A. In this
report, we show that Lex expression is not a stable trait
but that LPS displays a high frequency (0.2 to 0.5%) of phase
variation, resulting in the presence of several LPS variants in one
bacterial cell population. One type of phase variation implied the loss
of
1,3-linked fucose, resulting in variants that expressed
nonsubstituted polylactosamines (also called the i antigen), i.e.,
Lex minus fucose; LPS:
(lactosamine)n-core-lipid A. The switch of
Lex to i antigen was reversible. A second group of variants
arose by loss of polymeric main chain which resulted in expression of monomeric Ley; LPS: (Ley)-core-lipid A. A third
group of variants arose by acquisition of
1,2-linked fucose which
hence expressed Lex plus Ley; LPS:
(Ley)(Lex)n-core-lipid
A. The second and third group of variants switched back to the parental
phenotype [(Lex)n-core-lipid A]
in lower frequencies. Part of the variation can be ascribed to altered
expression levels of glycosyltransferase levels as assessed by assaying
the activities of galactosyl-, fucosyl-, and
N-acetylglucosaminyltransferases. Clearly phase variation
increases the heterogeneity of H. pylori, and this process may be involved in generating the very closely related yet genetically slightly different strains that have been isolated from one patient.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1,3-FucT and
1,4-galactosyltransferase [GalT]) has been demonstrated (1,
21), but it is not clear by what mechanisms serotype diversity is
generated.

View larger version (16K):
[in a new window]
FIG. 1.
Structures of Lewis-related antigens and H. pylori LPS. Abbreviations: Gal, D-galactose; Fuc,
L-fucose; GlcNAc,
N-acetyl-D-glucosamine.
Thus, the H. pylori O antigen expresses structures identical to that of the corresponding human blood group antigens present in the gastric mucosa (molecular mimicry) (2-4, 6, 21, 22). The identity of these LPS epitopes with molecules of the host may play a role in the induction of H. pylori-associated autoantibodies (1, 17, 18) and facilitate persistence in the gastric niche of humans (31).
We now report that expression of H. pylori LPS in a given strain is not a stable trait and that H. pylori LPS displays phase variation. From a single strain, we isolated various serotypes, all expressing different LPS structures and having different glycosyltransferase levels, which demonstrates that also in H. pylori, phase variation contributes to increased heterogeneity.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and cultivation procedures.
We
investigated three strains, all expressing Lewis x: the laboratory
strain NCTC 11637; strain 92-1152, isolated from a patient with gastric
carcinoma; and strain 3B3, isolated from the oral cavity of a patient
with gastritis (1, 22). Bacteria were stored at
80°C in
20% glycerol and were subcultured on solid medium (blood agar base
plus Dent supplement) before growth in the fluid phase (brucella broth
with 3% fetal calf serum) under microaerobic conditions (1,
22). Apart from B1.3 (see below), none of the strains
autoagglutinated.
MAbs. The following murine immunoglobulin M monoclonal antibodies (MAbs) were used: MAb 54.1F6A, specific for Lewis x (G. van Dam, Leiden, The Netherlands [25]); MAb 1E52, specific for Lewis y (R. Negrini, Brescia, Italy [1, 17, 18]); MAb 19-O-Le, specific for H type 2 and Lewis y (Bioprobe, Amstelveen, The Netherlands [1]); MAb 4D2, specific for H type 1 (R. Negrini [1, 17, 18]); and MAb NAM61-1A2, specific for i antigen (D. Blanchard, Nantes, France [5]). MAbs specific for Lewis x did not cross-react with H type 2/Lewis y or vice versa; the anti-i MAb did not react with Lewis x, H type 2, or Lewis y.
Isolation of H. pylori LPS mutants after UV irradiation. Overnight cultures of strain NCTC 11637 in brucella broth plus 3% fetal calf serum were centrifuged, suspended in 1 M MgSO4, serially diluted in phosphate-buffered saline, pH 7.5 (PBS), plated, and UV irradiated. Time, distance between plates UV light source, and dilution were chosen such that 10% of bacteria survived, resulting in 300 colonies per plate. Individual colonies were picked, transferred to each of two identical plates, and grown. The colonies were transferred to a nitrocellulose filter (0.45-µm pore size; Millipore Corporation, Bedford, Mass.) by pressing the filter to the surface of the plate. Mutants not expressing Lewis x were isolated as follows: colony blots were baked (1 h at 80°C), washed three times in PBS with 0.05% Tween 80 (PBST), and blocked with blocking buffer (Boehringer Mannheim, Almere, The Netherlands). Then blots were incubated overnight with anti-Lewis x MAb 54.1F6a, diluted in blocking buffer-PBST (1:1) at a concentration of 1 µg/ml. Blots were washed, incubated (1 h, 37°C) with goat anti-mouse immunoglobulin M-peroxidase (American Qualex, La Mirada, Calif.), diluted 1:1,000 in PBST plus 0.5% preimmune goat serum, and developed as described previously (29). Blots were inspected under a stereomicroscope at magnifications of up to ×64 and, when necessary, photographed. Nonreactive colonies were identified and subcultured at least twice, and purity was checked by colony blotting; finally, cells were grown in fluid medium, washed in PBS, and used in enzyme-linked immunosorbant assay (ELISA) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for further characterization. A modification of the procedure described above was also used: the nitrocellulose blotting paper was put on the irradiated plates, which resulted in almost complete transfer of the bacteria to the paper. Replicas of this first colony blot to a second and third nitrocellulose paper were made. One of the nitrocellulose replicas was put, colonies upward, on a fresh culture plate, a procedure that kept the bacteria alive. The remaining two blots were immunoprobed.
Isolation of variants. Spontaneously arising LPS variants were isolated from bacteria not subjected to UV irradiation by following the above-described modified protocol; i.e., bacteria were first grown in the fluid phase and distributed over solid media, after which immunodetection took place.
ELISA. The expression of various LPS epitopes on the parent strain, mutants, and variants was measured in ELISA. Bacteria grown in the fluid phase were washed in PBS, and coated at 7.5 × 106 CFU/ml on ELISA plates, and tested for reactivity with MAbs (1 µg/ml) as described elsewhere (1, 22).
SDS-PAGE, silver staining, and immunoblotting. The size distribution of LPS molecules of parent, mutants, and variants was analyzed by SDS-PAGE and silver staining. Bacterial cells were first digested with proteinase K and subjected to SDS-PAGE in 12% gels, and part of the gel was silver stained for LPS (13, 29). To localize particular LPS epitopes to particular LPS components, part of the gel was electroblotted to nitrocellulose. LPS epitopes were visualized as described above for colony blotting.
Glycosyltransferase assays.
GlcNAc
-O-(CH2)8-COOCH3 was
generously donated by O. Hindsgaul (University of Alberta, Edmonton,
Alberta, Canada),
Gal
1
4GlcNAc
-O-(CH2)8-COOCH3 was derived therefrom as described before (11).
GDP-[3H]Fuc (7.0 Ci/mmol), UDP-[3H]Gal (50 Ci/mmol), and UDP-[3H]GlcNAc (30.4 Ci/mmol) were
purchased from New England Nuclear (Boston, Mass.). The radioactive
nucleotide sugars were diluted to the desired specific radioactivity
with unlabeled GDP-Fuc (kind gift of H. Lönn and T. Nordberg,
Biocarb, Lund, Sweden), UDP-Gal, and UDP-GlcNAc (Sigma), respectively.
-O-(CH2)8-COOCH3, and 1 µl of enzyme; for N-acetylglucosaminyltransferase
(GlcNAcT), 5 µmol of sodium cacodylate buffer (pH 7.0), 1 µmol of
MnCl2, 0.2 µmol of ATP, 0.25 µl of Triton X-100, 25 nmol of UDP-[3H]GlcNAc (specific radioactivity, 0.75 Ci/mol), 50 nmol of
Gal
1
4GlcNAc
-O-(CH2)8-COOCH3, and 10 µl of enzyme; and for FucT, 5 µmol of sodium cacodylate buffer (pH 7.2), 1 µmol of MnCl2, 0.2 µmol of ATP, 0.25 µl of Triton X-100, 50 nmol of dithiothreitol, 25 nmol of
UDP-[3H]Fuc (specific radioactivity, 6.9 Ci/mol), 50 nmol
of
Gal
1
4GlcNAc
-O-(CH2)8-COOCH3, and 10 µl of enzyme. Mixtures were incubated for 1 h (GalT) or 5 h (GlcNAcT and FucT) at 37°C. Radioactivity incorporated into the acceptor substrate was determined by liquid scintillation counting
after isolation of the products by using Sep-Pak C18 cartridges (Waters, Milford, Mass.) as described previously
(6). Control assays lacking acceptor were carried out to
correct for incorporation into endogenous substrates. One unit of
enzyme activity is defined as the amount of enzyme catalyzing the
transfer of 1 µmol of sugar per min.
| |
RESULTS |
|---|
|
|
|---|
Phase variation in an H. pylori LPS mutant. Following UV irradiation, an LPS mutant (named B1.5) that lacked Lewis x expression and was strongly positive for Lewis y was isolated (for further characterization, see below). A colony blot of this mutant, probed with MAb 4D2, specific for H type 1, is shown in Fig. 2A. There are completely nonreactive colonies, colonies with reactive sectors only, and completely reactive (dark) colonies; this pattern indicates a spontaneous high-frequency clonal on switching of the H type 1 epitope.
|
Isolation of LPS variants from nonirradiated bacterial cells and demonstration of reversibility. Nonirradiated cells of strain NCTC 11637 and the two clinical isolates investigated also displayed phase variation behavior (Fig. 2B) but at a lower frequency. Figures 1 and 2B shows that NCTC 11637, which expresses Lewis x, has the ability to switch spontaneously to the expression of i antigen; strains expressing the i antigen did not express Lewis x (Table 1). Several of the colonies reactive with the anti-i MAb but nonreactive with anti-Lewis x, including variant K4.1, were subcultured. K4.1 was tested again to detect whether it could switch back to phenotype of the parent strain NCTC 11637. Indeed, K4.1 spontaneously switched to variants that reacted with anti-Lewis x MAbs but not with the anti-i MAb. The frequency of switching from Lewis x to i was determined in multiple experiments and equaled 49/11,080 (0.44%); the switchback frequency was 17/3,095 (0.55%). One of the switched-back variants (strain K5.1 [Table 1]) was isolated. Switching from Lewis x to i-antigen expression also took place in the two clinical isolates tested (not shown). Forty percent of the 106 clinical isolates tested proved positive for the i antigen. Parallel colony blots of NCTC 11637 probed with 19-O-Le (anti-Lewis y) and 54.1F6A (anti-Lewis x) (Fig. 2C and D, respectively) showed the presence of two other variants, i.e., variants that strongly expressed both Lewis x and y (for example, strain 1c [see below]; frequency, 0.5%) and variants that were strongly positive for Lewis y but did not express Lewis x (for example, strain 1b [see below]; frequency, 1.5%). The majority of the colonies strongly expressed Lewis x and reacted weakly with the anti-Lewis y MAb. Three such colonies (2a, 2b, and 3c) were subcultured and characterized. Their reactivity pattern was identical to that of the parental strain (Table 1).
|
Immunochemical analysis of variants.
Immunochemical data for
all mutants and variants isolated by us from strain NCTC 11637 are
shown in Table 1 and Fig. 3 and 4. Variant K4.1 (Fig. 3a) expressed an
LPS similar to that of the parent strain; both in ELISA and in blot
analysis, K4.1 (Fig. 3b) reacts with the anti-i MAb but not with
anti-Lewis x. Variant K5.1, a switchback variant isolated from K4.1,
behaves serologically like the parent strain: the O antigen expressed
Lewis x, not i antigen. We hypothesized that the switch from parent to
K4.1 implied the loss of
1,3-fucose, which was regained upon
switching from K4.1 to K5.1. Serologically, the mutants K1.4, K2.1, and
K3.1 were identical to the K4.1 variant. Figure 4 shows that variant 1b
had lost its polymeric main chain and now synthesized a
low-molecular-mass LPS expressing Lewis y but not Lewis x.
Serologically, mutants B1.5 and B2.1 are identical to variants B3.1 and
1b. Strain 1c expressed a polymeric Lewis x ladder, runs of the ladder
being capped with Lewis y and with slightly more runs in the
lower-molecular-weight zone compared to the parent. Variant 3a reacted
less than the parent or not at all with 4D2 in ELISA or blot analysis,
respectively. This variant expressed LPS that upon SDS-PAGE yielded a
smear instead of a ladder (see silver stain and blot in Fig. 4).
|
|
,
i+) switched back to Lewis x+, i
at a frequency of 0.2%. One K1.4 derived switchback variant (called K6.1 [data not shown]) was isolated and found to be able to switch to
Lewis x
, i+, which is further proof of the
reversibility of the Lewis x-to-i-antigen switch. In contrast, mutants
and variants that were Lewis x
, Lewis y+ did
not switch back (mutant B1.5, variant B3.1) or did so in extremely low
frequencies (variant 1b, switchback frequency, 1/1,400). We also did
not find switchbacks of variant 1c (Lewis x+, Lewis
y+). The serotype that most often is expressed by colonies
of NCTC 11637 (strong Lewis x+, weak Lewis y+;
variants 2b and 3c) switched to strong expression of Lewis
y+ at frequencies of 0.28 to 1%.
|
Glycosyltransferase assays. To study the enzymatic basis for the phenotypic differences observed, the activities of three relevant glycosyltransferases were assayed in some of the variants. Various activities were found (Table 3), with highest GalT activity in the parental strain (NCTC 11637) and highest FucT activity in variant 1c, while the activity of GlcNAcT was below the detection limit in variant 1b. Except for the latter variant, the GlcNAcT, GalT, and FucT activities appeared to vary over ranges of 2-, 8-, and 60-fold, respectively, suggesting that the gene coding for the latter enzyme in particular might be a target of mechanisms that causes phase variations.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this report, we show that H. pylori LPS displays
phase variation. Reversible Lewis x-to-i-antigen switching was
observed, at frequencies of about 0.4%. We also observed switches
implying loss of polymeric main chain (Lewis x
, Lewis
y+; for example, variant 1b) as well as switches implying
strong expression of Lewis y (Lewis x+, Lewis
y+; for example, variant 1c). By chemical means, strain
NCTC 11637 was shown to express Lewis x (2), but in the past
we have described the presence of low amounts of Lewis y in this strain
as measured by serology (1); this finding was confirmed in
this study. We assume that serology is more sensitive than
structural-chemical methods. The presence of nonfucosylated
polylactosamine stretches (i.e., the i antigen) has already been
demonstrated by chemical methods (2). Our report is the
first one on phase variation in H. pylori LPS; however,
Bukholm et al. (5a) have reported the occurrence of
reversible variants in colony morphology.
In previous reports (1, 18), we have suggested a pathogenic
role for H. pylori LPS-induced anti-Lewis antibodies that cross-react with gastric mucosal antigens of the host. To further study
the role of Lewis x, we isolated UV-induced Lewis x
mutants (Table 1). By serendipity, we discovered that a mutant (B1.5
[Fig. 2A]) displayed clonal expression of the epitope recognized by
MAb 4D2, specific for H type 1 antigen. However, no H type 1 antigen
can be detected in LPS of strain NCTC 11637 by structural-chemical means, and possibly the reactivity with strain 11637 represents a
cross-reaction. Due to these uncertainties, we did not study phase
variation of this epitope any further.
In contrast, the events taking place during phase variation of Lewis x
to i antigen (and vice versa) can be understood at the molecular level,
based on serological data (Table 1; Fig. 3) and on the primary
structure of the LPS of H. pylori NCTC 11637 (Fig. 1). We
postulate that the Lewis x antigen of strain 11637 switches to the i
antigen by loss of the
1,3-linked fucose. A summary of the
postulated LPS structures of the various variants and their possible
interrelationships is shown in Fig. 5.
The chemical structures of the LPS of the variants is under
investigation. The presence of FucT enzymatic activity in H. pylori has been reported (1, 6), and hence it was
conceivable that this Lewis x-to-i-antigen switch actually involved the
on and off switching of the gene coding for H. pylori
3-FucT. Variant K4.1 shows FucT activity yet is Lewis x negative.
Whether the measurement of FucT activities of a value in this respect
is not clear, because in the past it has been shown that strains
strongly positive for Lewis x may have lower FucT activities than
strains expressing less Lewis x (6). It is also conceivable
that genes coding for enzymes of the pathway leading to the donor
substrate for FucT, GDP-Fuc, are involved in the Lewis x-to-i phase
variation.
|
We observed the occurrence of i antigen to Lewis x switches first in strains that had been obtained from NCTC 11637 after UV irradiation (strains K1.4, K2.1, and K3.1). Later, switches were shown to occur also in nonirradiated cells. The reversibility of the phenomenon was investigated extensively, and we demonstrated that both spontaneous Lewis x-to-i-antigen switches and i antigen-to-Lewis x switches occurred at the same frequency, 0.44 and 0.55%, respectively. By using our colony blot procedures, we succeeded in isolating variants that had spontaneously switched from Lewis x to i antigen (e.g., K4.1) and a variant (K5.1) that had switched back again from i antigen to Lewis x. Mutants K1.4, K2.1, and K3.1 (all i+) also switched back spontaneously to Lewis x-positive cells, and one Lewis x-positive variant (K6.1 [data not shown]) that again switched to i+ at a frequency of 0.78% was isolated. In short, phase variation in the Lewis x to i antigen is reversible.
The presence in human sera of antibodies to the i antigen has been reported; these antibodies belong to the group of so-called cold agglutinins (CAs) (20). CAs recognize epitopes on erythrocytes and cause agglutination. As many H. pylori strains express the i antigen, it is possible that they induce CAs.
Second, we also studied mutants and variants that strongly expressed Lewis y and were negative for Lewis x (B1.5, B2.1, B3.1, and 1b [Table 1; Fig. 4]). Analysis of the lengths of these LPSs by SDS-PAGE showed that the polymeric main chain was lost. Apart from the core, only a single band could be seen. Strains that express Lewis y only, as determined both by chemical-structural analysis and by serology, have been described before (strain MO19 [4] and serotype O6 [1b]), and likely strains B1.5, B2.1, B3.1, and 1b are similar to MO19 and serotype O6 (Fig. 1). The single, Lewis y-expressing band (lanes 2 in Fig. 4a and 5b) likely represents a single Lewis y unit, covalently linked to the core. In contrast to the readily detected reversible phase variation Lewis x to i antigen, the switch from Lewis y to Lewis x was nondetectable in mutants B1.5 and variant B3.1 and with only one observed event of backswitching in strain 1b (Table 2). Again the similarity of the mutant and the variants is striking, and it is possible that those strains that we classified as mutants because they were isolated after UV irradiation simply are spontaneous phase variants.
In variant 1b, the switch from polylactosamine with multimeric Lewis x
to a single, Lewis y-carrying lactosamine unit appears to be due to a
complete turn off of a chain-elongating GlcNAcT, as no activity was
found with a substrate specific for such an enzyme. In mammals, the
GlcNAcTs that link GlcNAc residues to the core regions of protein- and
lipid-linked glycans differ from the aglycon-nonspecific
3-GlcNAcT
that is involved in the elongation of lactosamine chains (26,
27). Because in variant 1b only one lactosamine unit is present,
it is likely that also in H. pylori the attachment of a
GlcNAc to the
D-glycero-
-D-manno-heptose unit of the LPS core is catalyzed by a GlcNAcT that differs from the
elongating enzyme. Likely, the high expression of Lewis y by variant 1b
is caused by the absence of the GlcNAcT, which may compete with the
2-FucT for linking a glycosyl group to galactose. In addition, a
preferred action of the
2-FucT on short lactosamine chains rather
than elongated ones is possible.
Third, a switch from Lewis x to Lewis x plus Lewis y was observed
(strain 1c [Table 1; Fig. 4]). This variant expressed polymeric Lewis
x, forming a ladder structure like its parent strain but with a much
stronger expression of Lewis y; i.e., terminal
1,2-linked fucose is
strongly increased. Strains with this phenotype, as determined by
structural analysis and serology, have been described before (strain
P466 [4] and serotype O3 [1b]). We
did not observe backswitches of 1c to the parent phenotype. The
mechanism involved may be a switching from low to high levels of
expression of
2-FucT. It is known that in H. influenzae
LPS, phase variation may involve both off-to-on switches and switches
from low to high levels of expression (10).
The substrate used to assay FucT activity
[Gal
1
4GlcNAc
-O-(CH2)8-COOCH3]
did not allow us to discriminate between
2- and
3-FucT.
Previously it has been shown that using the same acceptor substrate the
FucT in several strains of H. pylori only catalyzed the
transfer of Fuc to GlcNAc in
1
3 linkage to yield the Lewis x
structure (6). The high FucT activity in variant 1c might, however, in part be due to a strongly enhanced activity of an
2-FucT
leading to the high expression of Lewis y. No such transfer could be
demonstrated in assays using a substrate
(Gal
-O-para-nitrophenol) that is known as a specific
acceptor for mammalian
2-FucTs (data not shown). It has, however,
been suggested that in the formation of Lewis y in H. pylori,
2-fucosylation may have to precede
3-fucosylation (16). Thus, it is conceivable that the high FucT activity in variant 1c reflects the consecutive transfers of Fuc residues in
1
3 and
1
2 linkage. Thus,
2-FucT may be involved in the switch from parental type to variant 1c. H. pylori FucT
genes have been identified (8, 16, 23) and expressed
(8, 16); these genes contain poly(C) tracts. Interestingly,
in strain NCTC 11637 (expressing Lewis x), the reported FucT gene
contains a C9 tract (gene off, truncated enzyme), while in strain
826695 (expressing Lewis xy [1a]), C13 is present
(gene on, full-length enzyme). These data suggest the possibility that
the expression of serotypes is regulated on the genetic level by means
of variable-length oligonucleotide repeats. They also suggest that the
mechanism of phase variation in H. pylori may mimic that of
H. influenzae. When screened with anti-Lewis y MAbs, most of
the colonies of strain NCTC 11637 stained only faintly, and we
demonstrated that those faintly staining colonies (that also strongly
express Lewis x) are the ones that switch to the variant with a high
expression of Lewis y (i.e., variants 1b and 1c [Fig. 2]).
Finally, variant 3a that expressed LPS that was less reactive or not reactive with MAb 4D2 did not yield the characteristic LPS ladder pattern. As yet, we have no indication as to the structural change that has taken place in this variant.
Phase variation contributes to the heterogeneity of H. pylori and may explain the finding that from one patient, several highly related yet different isolates may be obtained (28, 32). Whether phase variation-induced heterogeneity is functional or merely an epiphenomenon has not yet been assessed. The phenomenon occurred not only in the laboratory strain NCTC 11637, which has undergone many in vitro passages, but also in clinical isolates that had been passaged only a few times. Phase variation in LPS of N. gonorrhoeae or H. influenzae serves a biological role, one variant being more adequate in one situation (e.g., adherence to mucosal cells) and the other one being more resistant to killing by complement. It would be interesting to investigate if variants of one strain can be isolated differentially from different gastric sites of one patient or experimental animal (14) and to investigate whether certain variants adhere better. Further studies are required to assess the molecular mechanism of phase variation in H. pylori LPS and its biological relevance.
| |
ACKNOWLEDGMENTS |
|---|
We thank S. L. Martin (GlaxoWellcome, Stevenage, England), D. E. Taylor (University of Alberta, Edmonton, Alberta, Canada), and G. O. Aspinall (York University, North York, Ontario, Canada) for providing unpublished data. We thank R. Negrini (Brescia, Italy) and G. Van Dam (Leiden, The Netherlands) for providing MAbs.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology, Vrije Universiteit, Medical School, van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. Phone: 31 20 4448297. Fax: 31 20 4448318. E-mail: BJ.Appelmelk.mm{at}med.vu.nl.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Appelmelk, B. J., I. M. Simoons-Smit, R. Negrini, A. P. Moran, G. O. Aspinall, J. G. Forte, T. De Vries, H. Quan, T. Verboom, J. J. Maaskant, P. Ghiara, E. J. Kuipers, E. Bloemena, T. M. Tadema, R. R. Townsend, K. Tyagarajan, J. M. Crothers, Jr., M. A. Monteiro, A. Savio, and J. de Graaff. 1996. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64:2031-2040[Abstract]. |
| 1a. | Appelmelk, B. J. Unpublished data. |
| 1b. |
Aspinall, G. O.,
M. Monteiro,
R. T. Shaver,
L. A. Kurjanczyk, and J. L. Penner.
1997.
Lipopolysaccharides of Helicobacter pylori serogroups O:3 and O:6. Structures of a class of lipopolysaccharides with reference to the location of oligomeric units of D-glycero- -D-manno-heptose residues.
Eur. J. Biochem.
248:592-601[Medline].
|
| 2. | Aspinall, G. O., M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran. 1994. O antigen chains in the lipopolysaccharide of Helicobacter pylori NCTC 11637. Carbohydr. Lett. 1:151-156. |
| 3. | Aspinall, G. O., M. A. Monteiro, H. Pang, E. J. Walsh, and A. P. Moran. 1996. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen and core oligosaccharide regions. Biochemistry 35:2489-2497[Medline]. |
| 4. | Aspinall, G. O., and M. A. Monteiro. 1996. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide strains. Biochemistry 35:2498-2504[Medline]. |
| 5. | Blanchard, D., D. Bernard, M. J. Loirat, Y. Frioux, J. Guimbretiere, and L. Guimbretiere. 1992. Characterization of murine monoclonal antibodies directed to fetal erythrocytes. Rev. Fr. Transfus. Hemobiol. 35:239-254[Medline]. |
| 5a. | Bukholm, G., T. Tannaes, P. Nedenskov, Y. Esbensen, H. J. Gray, T. Hovig, S. Ariansen, and I. Goldvog. 1997. Colony variation of Helicobacter pylori: pathogenic potential is correlated to cell wall lipid composition. Scand. J. Gastroenterol. 32:445-454[Medline]. |
| 6. |
Chan, N. W. C.,
K. Stangier,
R. Sherburne,
D. E. Taylor,
Y. Zhang,
N. J. Dovichi, and M. M. Palcic.
1995.
The biosynthesis of Lewis x in Helicobacter pylori.
Glycobiology
5:683-688 |
| 7. | Covacci, A., S. Falkow, D. E. Berg, and R. Rappuoli. 1997. Did the inheritance of a pathogenicity island motif modify the virulence of Helicobacter pylori? Trends Microbiol. 5:205-208[Medline]. |
| 8. |
Ge, Z.,
N. W. C. Chan,
M. Palcic, and D. E. Taylor.
1997.
Cloning and heterologous expression of an 1,3-fucosyltransferase gene from the gastric pathogen Helicobacter pylori.
J. Biol. Chem.
272:21357-21363 |
| 9. |
Go, M. F.,
V. Kapur,
D. Y. Graham, and J. M. Musser.
1996.
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure.
J. Bacteriol.
178:3934-3938 |
| 10. | High, N. J., M. E. Deadman, and E. R. Moxon. 1993. The role of a repetitive DNA motif (5'-CAAT-3') in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope Gal(1-4)betaGal. Mol. Microbiol. 9:1275-1282[Medline]. |
| 11. |
Hokke, C. H.,
A. Zervosen,
L. Elling,
D. H. Joziasse, and D. H. Van den Eijnden.
1996.
One-pot enzymatic synthesis of the Gal 1 3Gal 1 4GlcNAc sequence with in situ UDP-Gal regeneration.
Glycoconjugate J.
13:687-692[Medline].
|
| 12. | Kuipers, E. J. 1997. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment. Pharmacol. Therapeut. 11(Suppl. 1):71-88. |
| 13. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 14. |
Lee, A.,
J. Orourke,
M. C. Deungria,
B. Robertson,
G. Daskalopoulos, and M. F. Dixon.
1997.
A standardized mouse model of Helicobacter pylori infection introduction of the Sydney strain.
Gastroenterology
112:1386-1397[Medline].
|
| 15. | Logan, P. H., and D. E. Berg. 1996. Genetic diversity of Helicobacter pylori. Lancet 348:1462-1463[Medline]. |
| 16. |
Martin, S. L.,
M. R. Edbroke,
T. C. Hodgman,
D. H. van den Eijnden, and M. I. Bird.
1997.
Lewis x biosynthesis in Helicobacter pylori: molecular cloning of an -(1,3)-fucosyltransferase gene.
J. Biol. Chem.
272:21349-21356 |
| 17. | Negrini, R., L. Lisato, I. Zanella, S. Cavazzini, S. Gullini, V. Villanacci, C. Poiesi, A. Albertini, and S. Ghielmi. 1991. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 101:437-445[Medline]. |
| 18. | Negrini, R., A. Savio, C. Poiesi, B. J. Appelmelk, F. Buffoli, A. Paterlini, P. Cesari, M. Graffeo, D. Vaira, and G. Franzin. 1996. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655-665[Medline]. |
| 19. | Roche, R. J., and E. R. Moxon. 1995. Phenotypic variation of carbohydrate surface antigens and the pathogenesis of Haemophilus influenzae infections. Trends Microbiol. 3:304-309[Medline]. |
| 20. | Roelcke, D. 1995. Serology, biochemistry, and pathology of antigens defined by cold agglutinins, p. 117-152. In J. P. Catron, and P. Rouger (ed.), Blood cell biochemistry, vol. 6. Molecular basis of major human blood group antigens. Plenum Press, New York, N.Y. |
| 21. | Sherburne, R., and D. E. Taylor. 1995. Helicobacter pylori expresses a complex surface carbohydrate, Lewis x. Infect. Immun. 63:4564-4568[Abstract]. |
| 22. | Simoons-Smit, I. M., B. J. Appelmelk, T. Verboom, R. Negrini, J. L. Penner, G. O. Aspinall, A. P. Moran, S. Fei-fei, S. Bi-shan, W. Rudnica, and J. de Graaff. 1996. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J. Clin. Microbiol. 34:2196-2200[Abstract]. |
| 23. | Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischman, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzgerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Bordovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and C. J. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547[Medline]. |
| 24. | Tsuda, M., M. Karita, and T. Nakazawi. 1993. Genetic transformation in Helicobacter pylori. Microbiol. Immunol. 37:85-89[Medline]. |
| 25. | Van Dam, G. J., A. A. Bergwerff, J. E. Thomas-Oates, J. P. Rotmans, J. P. Kamerling, J. F. Vliegenthart, and A. M. Deelder. 1994. The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from human blood fluke Schistosoma mansoni have Lewis x as repeating unit. Eur. J. Biochem. 225:467-82[Medline]. |
| 26. |
Van den Eijnden, D. H.,
A. H. L. Koenderman, and W. E. C. M. Schiphorst.
1988.
Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc: N-acetyllactosaminide 1 3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid.
J. Biol. Chem.
263:12461-12471 |
| 27. | Van den Eijnden, D. H., H. Bakker, A. P. Neeleman, I. M. Van den Nieuwenhof, and I. Van Die. 1997. Novel pathways in complex-type oligosaccharide synthesis: new vistas opened by studies in invertebrates. Biochem. Soc. Trans. 25:886-89328. |
| 28. | Van der Ende, A., E. A. J. Rauws, M. Feller, C. J. J. Mulder, G. N. J. Tytgat, and J. Dankert. 1996. Heterogenous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology 111:638-647[Medline]. |
| 29. |
Van der Meer, N. M.,
B. J. Appelmelk,
A. M. J. J. Verweij-van Vught,
W. Nimmich,
P. Kosma,
L. G. Thijs, and D. M. MacLaren.
1994.
Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid (Kdo) with a panel of Klebsiella pneumoniae lipopolysaccharides representing all the O serotypes.
Infect. Immun.
62:1052-1057 |
| 30. | Van Putten, J. P. M., and B. D. Robertson. 1995. Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria. Mol. Microbiol. 16:847-853[Medline]. |
| 31. | Wirth, H. P., M. Yang, R. M. Peek, K. T. Tham, and M. J. Blaser. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 113:1091-1098[Medline]. |
| 32. | Wirth, H. P., M. Yang, R. M. Peek, J. Hook-Nikanne, and M. J. Blaser. 1997. Phenotypic diversity in Lewis expression of H. pylori colonies derived from the same biopsy. Gastroenterology 112:A331. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»